Last reviewed · How we verify

NCT05176899

Real-World Evaluation of Eko Murmur Analysis Software in a Point of Care Setting

Terminated Last updated 19 September 2024
What this trial tests

trial testing Use of Eko CORE electronic stethoscope in Murmur, Heart in 103 participants. Terminated before completion.

Timeline
11 March 2022
Primary endpoint
3 August 2023
18 January 2024

Quick facts

Lead sponsorEko Devices, Inc.
StatusTerminated
Study typeOBSERVATIONAL
Enrollment103
Start date11 March 2022
Primary completion3 August 2023
Estimated completion18 January 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Eko Devices, Inc. — full company profile →

Who can join

50 and older, any sex, with Murmur, Heart or Innocent Murmurs. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research is to evaluate the impact of Eko AI plus EMAS (Eko Murmur Analysis Software) on a clinician's referral decision in a real-world primary care setting. There is an additional objective of understanding patient outcomes when patients are referred for cardiology follow-up and/or echocardiogram.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Eko Devices, Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05176899.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing